Cholera Vaccines Market Growth, Demand and Challenges of the Key Industry Players 2024-32

1
Global Cholera Vaccines Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Cholera Vaccines Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global cholera vaccines
  market size reached US 5.4 Million in 2023.
• Cholera is an acute intestinal disease that is
  generally caused by the consumption of
  contaminated water and food. It is spread by the
  Vibrio Cholerae bacteria that leads to pain in
  the abdomen, diarrhea, nausea, vomiting and
  water-electrolyte imbalance.
• Cholera vaccines are effective in stimulating the
  production of antibodies that aid in preventing
  the disease among individuals. Widely prepared
  using the live cholera-causing bacteria to aid in
  developing immunity against the same, these
  vaccines are directly injected intramuscularly or
  intradermally in the body.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/cholera-vaccines-market
  /requestsample

4
Report Description

• Global Cholera Vaccines Market Trends
• The global market is primarily driven by the
  escalating prevalence of cholera among the
  masses. This can be attributed to the poor
  sanitation and hygiene conditions in rural and
  geographically extended areas. Moreover, the
  rising awareness regarding the availability of
  cholera vaccines among the masses has propelled
  the product demand. In line with this, numerous
  initiatives undertaken by several government
  agencies and non-government organizations (NGOs)
  across multiple countries for conducting
  immunization programs are providing a boost to
  the demand for cholera vaccines.
• Along with this, the increasing investments and
  funding by public and private agencies for
  conducting extensive research and development
  (RD) activities are favorably impacting the
  market. Other factors, including the expanding
  healthcare expenditure, a considerable increase
  in water pollution levels, and the rising number
  of research laboratories and diagnosis centers,
  are also positively influencing the market
  growth.
• Looking forward, the market is anticipated to
  reach a value of US 13.0 Million by 2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/cholera-vaccines-market
  

5
Report Segmentation

• Breakup by Vaccine Type
• Whole Cell V. Cholerae O1 with Recombinant
  B-Subunit
• Killed Oral O1 and O139
•  
• Breakup by Product
• Dukoral
• Shanchol
• Vaxchora
• Euvichol and Euvichol-Plus
• Others
• Breakup by End User
• Hospitals and Clinics

6
Report Segmentation

• Research and Academic Laboratories
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Astellas Pharma Inc.
• Celldex Therapeutics Inc. (Avant
  Immunotherapeutics Inc.)
• Emergent BioSolutions Inc.
• Eubiologics Co. Ltd.
• Johnson Johnson
• Merck Co. Inc.
• Pfizer Inc.
• PharmaChoice Canada Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Valneva SE

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Cholera Vaccines
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Vaccine Type
• 6.1 Whole Cell V. Cholerae O1 with
  Recombinant B-Subunit
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Killed Oral O1 and O139
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Product
• 7.1 Dukoral
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

10
Table of Contents

• 7.2 Shanchol
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Vaxchora
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Euvichol and Euvichol-Plus
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 7.5 Others
• 7.5.1 Market Trends
• 7.5.2 Market Forecast
• 8 Market Breakup by End User
• 8.1 Hospitals and Clinics
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Research and Academic Laboratories
• 8.2.1 Market Trends
• 8.2.2 Market Forecast

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com